title: Practice guideline for diagnosis and management of migraine headaches in children and adolescents: Part two.
authors.affiliation: University of Texas Health Science Center at Houton, Houston, TX 77030, USA. kathy.gunner@comcast.net
authors.forename: Kathy B
authors.initials: KB
authors.lastname: Gunner
authors.forename: Holly D
authors.initials: HD
authors.lastname: Smith
authors.forename: Laura E
authors.initials: LE
authors.lastname: Ferguson
mesh_terms: D000293:Adolescent; D000700:Analgesics / Q000627:therapeutic use; D001676:Biofeedback, Psychology; D002648:Child; D053198:Child Nutrition Sciences / Q000193:education; D004087:Dihydroergotamine / Q000627:therapeutic use; D015444:Exercise; D005247:Feeding Behavior; D006801:Humans; D007255:Information Services; D008499:Medical Records; D008881:Migraine Disorders / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D009722:Nurse Practitioners / Q000458:organization & administration*; D009730:Nursing Assessment; D010347:Patient Care Planning / Q000458:organization & administration*; D010353:Patient Education as Topic; D010371:Pediatric Nursing / Q000458:organization & administration*; D012064:Relaxation Therapy; D012307:Risk Factors; D012648:Self Care; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use; D018170:Sumatriptan / Q000627:therapeutic use; D014662:Vasoconstrictor Agents
chemical_list: D000700:Analgesics; D017366:Serotonin Receptor Agonists; D014662:Vasoconstrictor Agents; D004087:Dihydroergotamine; D018170:Sumatriptan